FDA accelerates registration process for generic drugs
Category
🗞
NewsTranscript
00:00 The Food and Drug Administration, or FDA, has accelerated the registration process for
00:04 generic drugs in the country.
00:06 In accordance with the directive of President Ferdinand R. Marcus Jr., the agency shortened
00:11 the process to 40 days from the previous 120 days.
00:15 The Facilitated Review Pathway, or FPR, released by FDA aims to provide an alternative process
00:22 to those who want to register their generic drugs.
00:25 Moreover, FDA also ensures that the generic drug that will be purchased by the public
00:30 is affordable, safe, effective, and of good quality.